Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23012398)

1.

Iron homeostasis in porphyria cutanea tarda: mutation analysis of promoter regions of CP, CYBRD1, HAMP and SLC40A1.

Panton NA, Strickland NJ, Hift RJ, Warnich L, Zaahl MG.

J Clin Pathol. 2013 Feb;66(2):160-1. doi: 10.1136/jclinpath-2012-200988. Epub 2012 Sep 25. No abstract available.

PMID:
23012398
2.

Absence of functional mutations in the ferroportin-encoding SLC40A1 gene in porphyria cutanea tarda: a series of 37 cases from southern France.

Du Thanh A, Martinez P, Cunat S, Bessis D, Guillot B, Dereure O.

Acta Derm Venereol. 2011 Jun;91(4):467. doi: 10.2340/00015555-0987. No abstract available.

3.

Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.

Zaahl MG, Merryweather-Clarke AT, Kotze MJ, van der Merwe S, Warnich L, Robson KJ.

Hum Genet. 2004 Oct;115(5):409-17. Epub 2004 Aug 24.

PMID:
15338274
4.

Hemojuvelin and hepcidin gene mutations in patients with porphyria cutanea tarda from Southern France.

Du Thanh A, Aguilar-Martinez P, Cunat S, Bessis D, Guillot B, Dereure O.

Acta Derm Venereol. 2011 Jan;91(1):66-7. doi: 10.2340/00015555-0853. No abstract available.

5.

Down-regulation of hepcidin in porphyria cutanea tarda.

Ajioka RS, Phillips JD, Weiss RB, Dunn DM, Smit MW, Proll SC, Katze MG, Kushner JP.

Blood. 2008 Dec 1;112(12):4723-8. doi: 10.1182/blood-2008-02-138222. Epub 2008 Sep 22.

6.

Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.

Bygum A, Christiansen L, Petersen NE, Hørder M, Thomsen K, Brandrup F.

Acta Derm Venereol. 2003;83(2):115-20.

PMID:
12735639
7.

Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.

Fargion S, Fracanzani AL, Romano R, Cappellini MD, Faré M, Mattioli M, Piperno A, Ronchi G, Fiorelli G.

J Hepatol. 1996 May;24(5):564-9.

PMID:
8773911
8.

High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.

Kratka K, Dostalikova-Cimburova M, Michalikova H, Stransky J, Vranova J, Horak J.

Br J Dermatol. 2008 Sep;159(3):585-90. doi: 10.1111/j.1365-2133.2008.08693.x. Epub 2008 Jun 28.

PMID:
18565178
9.

Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.

Mayr R, Griffiths WJ, Hermann M, McFarlane I, Halsall DJ, Finkenstedt A, Douds A, Davies SE, Janecke AR, Vogel W, Cox TM, Zoller H.

Gastroenterology. 2011 Jun;140(7):2056-63, 2063.e1. doi: 10.1053/j.gastro.2011.02.064. Epub 2011 Mar 9.

PMID:
21396368
10.

HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.

Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH.

Am J Hematol. 2009 Nov;84(11):710-4. doi: 10.1002/ajh.21524.

PMID:
19787796
11.

Clinicopathological study of Japanese patients with genetic iron overload syndromes.

Hattori A, Miyajima H, Tomosugi N, Tatsumi Y, Hayashi H, Wakusawa S.

Pathol Int. 2012 Sep;62(9):612-8. doi: 10.1111/j.1440-1827.2012.02848.x.

PMID:
22924847
12.

[Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].

Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H.

Ann Dermatol Venereol. 2001 May;128(5):600-4. French.

13.

The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.

Toll A, Celis R, Ozalla MD, Bruguera M, Herrero C, Ercilla MG.

J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1201-6.

PMID:
17062032
14.

Extremely rare association of HFE mutations with porphyria cutanea tarda in Japanese patients.

Furuyama K, Kondo M, Hirata K, Fujita H, Sassa S.

Hepatology. 1999 Dec;30(6):1532-3. No abstract available.

PMID:
10610355
15.

Age-related changes in iron homeostasis in mouse ferroxidase mutants.

Chen H, Attieh ZK, Gao H, Huang G, Su T, Ke W, Vulpe CD.

Biometals. 2009 Oct;22(5):827-34. doi: 10.1007/s10534-009-9229-0. Epub 2009 Mar 28.

PMID:
19330300
16.

C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria.

Ivanova A, von Ahsen N, Adjarov D, Krastev Z, Oellerich M, Wieland E.

Hepatology. 1999 Dec;30(6):1531-2. No abstract available.

PMID:
10610354
17.

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.

Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH.

J Hepatol. 1998 Mar;28(3):404-9.

PMID:
9551677
18.

The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.

Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, Wilson JH.

J Hepatol. 1995 Sep;23(3):259-67.

PMID:
8550989
20.

TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda.

Dongiovanni P, Valenti L, Fracanzani AL, Cappellini MD, Fargion S, Taioli E.

Dig Liver Dis. 2003 Aug;35(8):596-7. No abstract available.

PMID:
14567466
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk